Amgen, Inc. (NASDAQ:AMGN)

biotech word cloud

Major Biotech Short Interest Continues to Be Mixed

The short interest data are out for the January 29 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
ThinkstockPhotos-481735362

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

When some investors think about biotech, the first thoughts are of incredibly volatile companies, with clinical data and binary outcomes that can make the stocks swing up and down wildly. ...
Read Full Story »
Test tubes

Amgen Posts Handy Beat on Estimates and Guidance

Amgen Inc. (NASDAQ: AMGN) reported fourth-quarter financial results after the markets closed Thursday. The company had $2.61 in earnings per share (EPS) on $5.54 billion in revenue, compared to consensus ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the January 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. There is a challenging macro setup, but headwinds combined with a relatively attractive valuation could carry ...
Read Full Story »
Test tubes

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
New York Stock Exchange

10 Top 2016 Stock Picks From Goldman Sachs, Merrill Lynch and Other Key Analysts

It is a new year and the bull market may seem a bit interrupted now that 2015 brought no net gain in the Dow Jones Industrial Average and the S&P ...
Read Full Story »
bull and bear

5 Top Goldman Sachs Stocks to Buy for 2016

As 2015 slides into 2016, many investors have been making their portfolios positioned for less of a raging bull market than they have seen for the past six years or ...
Read Full Story »
biotech word cloud

Short Interest Remains Mixed in Major Biotechs

The short interest data are out for the December 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Millennium Falcon

4 High-Flying Stocks That Could Fly Even Higher in 2016

While buy low, sell high is the best way to make money quantitatively, it requires impeccable timing and more nerve than most investors possess. Buy high, sell higher is more ...
Read Full Story »
Test tubes

4 Top Biotech Stocks for 2016

Biotech looks set to close out 2015 as its worst performing year since 2008. That may sound bad, but despite this, the iShares Biotechnology Index ETF (NASDAQ: IBB) is still ...
Read Full Story »
ThinkstockPhotos-486788030

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Amgen Inc. (NASDAQ: AMGN) is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock. The reality is that ...
Read Full Story »
biotech word cloud

Mixed Views on Major Biotech Short Interest

The short interest data are out for the November 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Test tubes

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the November 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Hepatitis Virus

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the October 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »